Aclaris Therapeutics, Inc.
ACRS
Revenue
3.30M
▲1.52M▲85.65%
3 Months ChangeAssets
175.53M
▼-13.61M▼-7.20%
3 Months ChangeLiabilities
55.43M
▼-1.97M▼-3.44%
3 Months ChangeFree Cash Flow
-13.10M
▲7.85M▲37.47%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-07
Form 10-Q
ID: 0001558370-24-011376
2024-08-07
Form 8-K
ID: 0001558370-24-011201
2024-07-16
Form 8-K
ID: 0001558370-24-009853
2024-06-07
Form 8-K
ID: 0001558370-24-009009
2024-05-07
Form 10-Q
ID: 0001558370-24-007069
2024-05-07
Form 8-K
ID: 0001558370-24-007055
2024-03-19
Form 8-K
ID: 0001558370-24-003572
2024-02-27
Form 8-K
ID: 0001558370-24-001752
2024-02-05
Form 8-K
ID: 0001558370-24-000769
2024-01-19
Form 8-K
ID: 0001558370-24-000373